Neoadjuvant Dalpiciclib, Exemestane, and Goserelin in Premenopausal Women with HR-positive, HER2-negative Breast Cancer: A Prospective, Multicenter, Randomized Two-Group, Non-Controlled Phase 2 Clinical Trial.
Journal of Clinical Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要